{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,5]],"date-time":"2026-06-05T13:57:29Z","timestamp":1780667849395,"version":"3.54.1"},"reference-count":35,"publisher":"Elsevier BV","issue":"7-8","license":[{"start":{"date-parts":[[2025,11,1]],"date-time":"2025-11-01T00:00:00Z","timestamp":1761955200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,11,1]],"date-time":"2025-11-01T00:00:00Z","timestamp":1761955200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["clinicalkey.fr","em-consulte.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Cancer\/Radioth\u00e9rapie"],"published-print":{"date-parts":[[2025,11]]},"DOI":"10.1016\/j.canrad.2025.104752","type":"journal-article","created":{"date-parts":[[2025,10,15]],"date-time":"2025-10-15T14:28:29Z","timestamp":1760538509000},"page":"104752","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":2,"title":["Radiotherapy for endometrial cancer: 2025 update"],"prefix":"10.1016","volume":"29","author":[{"given":"Cyrus","family":"Chargari","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anne","family":"Ducassou","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Julie","family":"Leblanc","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fran\u00e7ois","family":"Lucia","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Adeline","family":"Petit","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Isabelle","family":"Flandin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Abel","family":"Cordoba","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Caroline","family":"Lafond","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sophie","family":"Renard","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alexandre","family":"Escande","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"1","key":"10.1016\/j.canrad.2025.104752_bib0005","first-page":"7","article-title":"Cancer research, 2020","volume":"70","author":"Siegel","year":"2020","journal-title":"CA Cancer J Clin"},{"key":"10.1016\/j.canrad.2025.104752_bib0010","doi-asserted-by":"crossref","first-page":"103","DOI":"10.1016\/j.ijgo.2009.02.012","article-title":"staging for carcinoma of vulva, cervix and endometrium","volume":"105","author":"Pecorelli","year":"2009","journal-title":"Int J Gynaecol Obstet"},{"issue":"1\u20132","key":"10.1016\/j.canrad.2025.104752_bib0015","doi-asserted-by":"crossref","first-page":"309","DOI":"10.1016\/j.canrad.2021.11.016","article-title":"Radiotherapy for endometrial cancer","volume":"26","author":"Chargari","year":"2022","journal-title":"Cancer Radiother"},{"issue":"11","key":"10.1016\/j.canrad.2025.104752_bib0020","doi-asserted-by":"crossref","first-page":"e602","DOI":"10.1016\/S1470-2045(24)00262-6","article-title":"Fertility-sparing treatment and follow-up in patients with cervical cancer, ovarian cancer, and borderline ovarian tumours: guidelines from ESGO, ESHRE, and ESGE","volume":"25","author":"Morice","year":"2024","journal-title":"Lancet Oncol"},{"key":"10.1016\/j.canrad.2025.104752_bib0025","doi-asserted-by":"crossref","first-page":"327","DOI":"10.1016\/j.radonc.2020.11.018","article-title":"ESGO\/ESTRO\/ESP guidelines for the management of patients with endometrial carcinoma","volume":"154","author":"Concin","year":"2021","journal-title":"Radiother Oncol"},{"issue":"12","key":"10.1016\/j.canrad.2025.104752_bib0030","doi-asserted-by":"crossref","first-page":"1039","DOI":"10.1016\/j.bulcan.2017.07.009","article-title":"Clinical trials and perspectives of radiotherapy for uterine endometrial cancers","volume":"104","author":"Chargari","year":"2017","journal-title":"Bull Cancer"},{"issue":"8","key":"10.1016\/j.canrad.2025.104752_bib0035","doi-asserted-by":"crossref","first-page":"719","DOI":"10.1016\/j.canrad.2024.10.002","article-title":"Transformative clinical trials in gynaecologic radiation oncology in 2023-2024: Shaping modern treatment practices","volume":"28","author":"El Ayachi","year":"2024","journal-title":"Cancer Radiother"},{"issue":"24","key":"10.1016\/j.canrad.2025.104752_bib0040","doi-asserted-by":"crossref","first-page":"2317","DOI":"10.1056\/NEJMoa1813181","article-title":"Adjuvant chemotherapy plus radiation for locally advanced endometrial cancer","volume":"380","author":"Matei","year":"2019","journal-title":"N Engl J Med"},{"issue":"21","key":"10.1016\/j.canrad.2025.104752_bib0045","doi-asserted-by":"crossref","first-page":"1810","DOI":"10.1200\/JCO.18.01575","article-title":"Phase III trial: adjuvant pelvic radiation therapy versus vaginal brachytherapy plus paclitaxel\/carboplatin in high-intermediate and high-risk early stage endometrial cancer","volume":"37","author":"Randall","year":"2019","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.canrad.2025.104752_bib0050","doi-asserted-by":"crossref","first-page":"1404","DOI":"10.1016\/S0140-6736(00)02139-5","article-title":"Surgery and postoperative radiotherapy versus surgery alone for patients with stage-1 endometrial carcinoma: multicentre randomised trial. PORTEC Study group. Post operative radiation therapy in endometrial carcinoma","volume":"355","author":"Creutzberg","year":"2000","journal-title":"Lancet"},{"key":"10.1016\/j.canrad.2025.104752_bib0055","doi-asserted-by":"crossref","first-page":"816","DOI":"10.1016\/S0140-6736(09)62163-2","article-title":"Vaginal brachytherapy versus pelvic external beam radiotherapy for patients with endometrial cancer of high-intermediate risk (PORTEC-2): an open-label, non-inferiority, randomised trial","volume":"375","author":"Nout","year":"2010","journal-title":"Lancet"},{"key":"10.1016\/j.canrad.2025.104752_bib0060","doi-asserted-by":"crossref","first-page":"834","DOI":"10.1016\/j.ijrobp.2005.03.007","article-title":"Postoperative radiotherapy for Stage 1 endometrial carcinoma: long-term outcome of the randomized PORTEC trial with central pathology review","volume":"63","author":"Scholten","year":"2005","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.canrad.2025.104752_bib0065","doi-asserted-by":"crossref","first-page":"1249","DOI":"10.1016\/j.ijrobp.2011.04.014","article-title":"External pelvic and vaginal irradiation versus vaginal irradiation alone as postoperative therapy in medium-risk endometrial carcinoma?. A prospective randomized study","volume":"82","author":"Sorbe","year":"2012","journal-title":"Int J Radiat Oncol"},{"key":"10.1016\/j.canrad.2025.104752_bib0070","doi-asserted-by":"crossref","first-page":"266","DOI":"10.1038\/sj.bjc.6603279","article-title":"Adjuvant chemotherapy vs radiotherapy in high-risk endometrial carcinoma: results of a randomised trial","volume":"95","author":"Maggi","year":"2006","journal-title":"Br J Cancer"},{"issue":"29","key":"10.1016\/j.canrad.2025.104752_bib0075","doi-asserted-by":"crossref","first-page":"3388","DOI":"10.1200\/JCO.20.00549","article-title":"Molecular classification of the PORTEC-3 trial for high-risk endometrial cancer: impact on prognosis and benefit from adjuvant therapy","volume":"38","author":"Le\u00f3n-Castillo","year":"2020","journal-title":"J Clin Oncol"},{"issue":"3","key":"10.1016\/j.canrad.2025.104752_bib0080","doi-asserted-by":"crossref","first-page":"295","DOI":"10.1016\/S1470-2045(18)30079-2","article-title":"Adjuvant chemoradiotherapy versus radiotherapy alone for women with high-risk endometrial cancer (PORTEC-3): final results of an international, open-label, multicentre, randomised, phase 3 trial","volume":"19","author":"de Boer","year":"2018","journal-title":"Lancet Oncol"},{"issue":"12","key":"10.1016\/j.canrad.2025.104752_bib0085","doi-asserted-by":"crossref","first-page":"2002","DOI":"10.1136\/ijgc-2020-001929","article-title":"PORTEC-4a: international randomized trial of molecular profile-based adjuvant treatment for women with high-intermediate risk endometrial cancer","volume":"30","author":"van den Heerik","year":"2020","journal-title":"Int J Gynecol Cancer"},{"issue":"2","key":"10.1016\/j.canrad.2025.104752_bib0090","doi-asserted-by":"crossref","first-page":"383","DOI":"10.1002\/ijgo.14923","article-title":"FIGO staging of endometrial cancer: 2023","volume":"162","author":"Berek","year":"2023","journal-title":"Int J Gynaecol Obstet"},{"issue":"8","key":"10.1016\/j.canrad.2025.104752_bib171","doi-asserted-by":"crossref","first-page":"e423","DOI":"10.1016\/S1470-2045(25)00167-6","article-title":"ESGO-ESTRO-ESP guidelines for the management of patients with endometrial carcinoma: update 2025","volume":"26","author":"Concin","year":"2025","journal-title":"Lancet Oncol"},{"issue":"23","key":"10.1016\/j.canrad.2025.104752_bib0095","doi-asserted-by":"crossref","first-page":"4949","DOI":"10.1158\/1078-0432.CCR-23-1397","article-title":"Clinical behavior and molecular landscape of stage I p53-abnormal low-grade endometrioid endometrial carcinomas","volume":"29","author":"Jamieson","year":"2023","journal-title":"Clin Cancer Res"},{"issue":"5","key":"10.1016\/j.canrad.2025.104752_bib0170","first-page":"386","article-title":"Brachytherapy: an overview for clinicians","volume":"69","author":"Chargari","year":"2019","journal-title":"CA Cancer J Clin"},{"issue":"21","key":"10.1016\/j.canrad.2025.104752_bib0100","doi-asserted-by":"crossref","first-page":"1810","DOI":"10.1200\/JCO.18.01575","article-title":"Phase III trial: adjuvant pelvic radiation therapy versus vaginal brachytherapy plus paclitaxel\/carboplatin in high-intermediate and high-risk early stage endometrial cancer","volume":"37","author":"Randall","year":"2019","journal-title":"J Clin Oncol"},{"issue":"24","key":"10.1016\/j.canrad.2025.104752_bib0105","doi-asserted-by":"crossref","first-page":"2317","DOI":"10.1056\/NEJMoa1813181","article-title":"Adjuvant chemotherapy plus radiation for locally advanced endometrial cancer","volume":"380","author":"Matei","year":"2019","journal-title":"N Engl J Med"},{"issue":"19","key":"10.1016\/j.canrad.2025.104752_bib0110","doi-asserted-by":"crossref","first-page":"4750","DOI":"10.3390\/cancers15194750","article-title":"Stages I-III inoperable endometrial carcinoma: a retrospective analysis by the Gynaecological Cancer GEC-ESTRO Working Group of patients treated with external beam irradiation and 3D-image guided brachytherapy","volume":"15","author":"Rovirosa","year":"2023","journal-title":"Cancers (Basel)"},{"issue":"4","key":"10.1016\/j.canrad.2025.104752_bib0115","doi-asserted-by":"crossref","first-page":"906","DOI":"10.3390\/cancers14040906","article-title":"Role of brachytherapy in the postoperative management of endometrial cancer: decision-making analysis among experienced european radiation oncologists","volume":"14","author":"Glatzer","year":"2022","journal-title":"Cancers (Basel)"},{"issue":"1","key":"10.1016\/j.canrad.2025.104752_bib0120","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1016\/j.ygyno.2019.01.007","article-title":"Association of chemotherapy and radiotherapy sequence with overall survival in locoregionally advanced endometrial cancer","volume":"153","author":"Goodman","year":"2019","journal-title":"Gynecol Oncol"},{"issue":"6","key":"10.1016\/j.canrad.2025.104752_bib0125","doi-asserted-by":"crossref","first-page":"1226","DOI":"10.3390\/cancers13061226","article-title":"Image-guided brachytherapy for salvage reirradiation: a systematic review","volume":"13","author":"Bockel","year":"2021","journal-title":"Cancers (Basel)"},{"issue":"1","key":"10.1016\/j.canrad.2025.104752_bib0130","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1016\/j.canrad.2023.06.012","article-title":"Place of radiotherapy for treatment of metastatic cervical, vaginal and endometrial uterine cancer","volume":"28","author":"Escande","year":"2024","journal-title":"Cancer Radiother"},{"issue":"2","key":"10.1016\/j.canrad.2025.104752_bib0135","doi-asserted-by":"crossref","first-page":"323","DOI":"10.1016\/j.ygyno.2020.05.032","article-title":"Implementation of image-guided brachytherapy as part of non-surgical treatment in inoperable endometrial cancer patients","volume":"158","author":"Espenel","year":"2020","journal-title":"Gynecol Oncol"},{"issue":"3","key":"10.1016\/j.canrad.2025.104752_bib0140","doi-asserted-by":"crossref","first-page":"654","DOI":"10.1016\/j.ijrobp.2022.09.072","article-title":"GEC-ESTRO (ACROP)-ABS-CBG consensus brachytherapy target definition guidelines for recurrent endometrial and cervical tumors in the vagina","volume":"115","author":"Kamrava","year":"2023","journal-title":"Int J Radiat Oncol Biol Phys"},{"issue":"2","key":"10.1016\/j.canrad.2025.104752_bib0145","doi-asserted-by":"crossref","first-page":"428","DOI":"10.1016\/j.ijrobp.2007.09.042","article-title":"Consensus guidelines for delineation of clinical target volume for intensity-modulated pelvic radiotherapy in postoperative treatment of endometrial and cervical cancer","volume":"71","author":"Small","year":"2008","journal-title":"Int J Radiat Oncol Biol Phys"},{"issue":"1","key":"10.1016\/j.canrad.2025.104752_bib0150","doi-asserted-by":"crossref","first-page":"83","DOI":"10.1016\/j.ijrobp.2013.01.017","article-title":"Hematologic toxicity on RTOG 0418: a phase II study of postoperative IMRT for gynecologic cancer","volume":"86","author":"Klopp","year":"2013","journal-title":"Int J Radiat Oncol Biol Phys"},{"issue":"24","key":"10.1016\/j.canrad.2025.104752_bib0155","doi-asserted-by":"crossref","first-page":"2538","DOI":"10.1200\/JCO.2017.77.4273","article-title":"Patient-reported toxicity during pelvic intensity-modulated radiation therapy: NRG Oncology-RTOG 1203","volume":"36","author":"Klopp","year":"2018","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.canrad.2025.104752_bib0160","doi-asserted-by":"crossref","first-page":"1354","DOI":"10.1016\/S0360-3016(03)00325-0","article-title":"Preliminary analysis of chronic gastrointestinal toxicity in gynecology patients treated with intensity-modulated whole pelvic radiation therapy","volume":"56","author":"Mundt","year":"2003","journal-title":"Int J Radiat Oncol Biol Phys"},{"issue":"7\u20138","key":"10.1016\/j.canrad.2025.104752_bib0165","doi-asserted-by":"crossref","first-page":"104753","DOI":"10.1016\/j.canrad.2025.104753","article-title":"Radiotherapy and brachytherapy for cervical cancer: recommendations of the Soci\u00e9t\u00e9 fran\u00e7aise de radioth\u00e9rapie oncologique","volume":"29","author":"Chargari","year":"2025","journal-title":"Cancer Radiother"}],"container-title":["Cancer\/Radioth\u00e9rapie"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1278321825001684?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1278321825001684?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,1,18]],"date-time":"2026-01-18T12:15:17Z","timestamp":1768738517000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1278321825001684"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,11]]},"references-count":35,"journal-issue":{"issue":"7-8","published-print":{"date-parts":[[2025,11]]}},"alternative-id":["S1278321825001684"],"URL":"https:\/\/doi.org\/10.1016\/j.canrad.2025.104752","relation":{},"ISSN":["1278-3218"],"issn-type":[{"value":"1278-3218","type":"print"}],"subject":[],"published":{"date-parts":[[2025,11]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Radiotherapy for endometrial cancer: 2025 update","name":"articletitle","label":"Article Title"},{"value":"Cancer\/Radioth\u00e9rapie","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.canrad.2025.104752","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 Soci\u00e9t\u00e9 fran\u00e7aise de radioth\u00e9rapie oncologique (SFRO). Published by Elsevier Masson SAS. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}],"article-number":"104752"}}